查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2003127

伴侣动物诊断市场：2026-2032年全球市场预测（依诊断测试类型、产品类型、动物种类、最终用户和应用划分）

Companion Animal Diagnostics Market by Type Of Diagnostic Test, Product Type, Animal Type, End-User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，宠物诊断市场价值将达到 35.9 亿美元，到 2026 年将成长到 39 亿美元，到 2032 年将达到 65.5 亿美元，复合年增长率为 8.94%。

主要市场统计数据
基准年 2025 35.9亿美元
预计年份：2026年 39亿美元
预测年份 2032 65.5亿美元
复合年增长率 (%) 8.94%

对不断发展的伴侣动物诊断领域进行简要概述，重点关注正在重塑我们提供护理方式的技术、临床和监管驱动因素。

伴侣动物诊断领域正经历着快速变革时期，这主要得益于技术创新、临床实践的改变以及饲主对更精准、更快捷的兽医服务的日益增长的期望。检测设计、影像技术和分子技术的进步使得疾病的早期发现、更个人化的治疗方案以及对治疗效果的更佳监测成为可能。随着兽医院采用更先进的院内检测能力，即时筛检（POC​​）和检查室诊断之间的界线日益模糊，兽医院和专科中心的流程模式和服务提供方式也在不断重组。

这清楚地概述了将改变整体诊断技术、临床工作流程和经营模式的关键变革。

伴侣动物诊断领域正经历一场变革，多项变革共同推动着产业提案的重塑。首先，分子诊断和次世代定序的成熟使得诊断工具包超越了传统的形态学和血清学检测，能够实现病原体的精准鑑定、遗传风险分析和标靶肿瘤检测。同时，即时检测技术和小型分析仪的普及使得检测分散化，许多诊所能够在内部进行血液检测、生物化学检验和快速感染疾病检测。这缩短了诊断时间，并促进了即时的临床干预。

对 2025 年关税调整将如何影响供应链韧性、区域筹资策略和临床医生采购行为进行实际分析。

计划于2025年实施的关税调整和贸易政策变化，为伴侣动物诊断供应链中的製造商、经销商和终端用户带来了新的营运挑战。某些市场对医疗设备和试剂征收更高的关税，给依赖全球采购的供应商的利润率带来了压力，迫使他们重新评估其分销策略、定价模式和供应商关係。拥有地理位置分散的生产基地和灵活的契约製造安排的製造商，更有能力缓解短期成本压力，并稳定向兽医院和检查室供应的供应链。

详细的细分洞察揭示了诊断测试类型、产品类型、目标动物群、最终用户环境和临床应用如何塑造策略重点。

精细化的细分观点能够清楚地展现临床需求、技术适用性和商业性机会在多个诊断类别中的交会点。 「诊断测试类型」维度涵盖血液学测试，例如血液凝固检查和血液常规检查；组织病理学方法，包括切片检查和细胞学工作流程；影像学方法，涵盖超音波和X射线诊断；分子诊断平台，从DNA定序到基于PCR的检测；以及血清学方法，包括凝集试验和ELISA。每种测试类型都有其独特的分析要求、检体处理程序和培训需求，这些都会影响兽医医院和检测实验室的采购决策。

战略区域洞察，阐述美洲、欧洲、中东和非洲以及亚太市场在技术采用、监管和经营模式方面的差异。

区域趋势对技术采纳、监管路径和商业性实施策略有显着影响。在美洲，专业兽医诊所和先进实验室的集中分布，以及完善的分销网络和成熟的私人诊所生态系统，正推动着高通量分子诊断和整合临床管理流程的快速普及。相较之下，欧洲、中东和非洲（EMEA）的情况则更为复杂，监管协调的努力与市场分散并存。西欧成熟的兽医中心推动了对检验和认证的解决方案的需求，而新兴市场则优先考虑能够应对区域疾病负担且经济高效、适应性强的诊断方案。

从企业层面提供实用见解，重点介绍竞争差异化策略、合作途径和创新重点，以维持可持续的市场地位。

随着老牌製造商、专业仪器製造商、试剂供应商和创新分子诊断公司寻求差异化的价值提案，伴侣动物诊断领域的竞争动态正在不断演变。成功越来越依赖整合式交付系统，该系统需结合可靠的仪器和检验的耗材、精简的工作流程以及完善的售后服务支援。投资于临床证据、第三方检验和跨物种参考数据的公司能够赢得兽医和检查室管理人员的信任，有助于维持长期的采购合作关係。

为行业领导者提供切实可行的、优先考虑的建议，以协调产品、证据、定价和分销策略，从而促进临床引入和发展。

产业领导者可以透过调整产品、证据和市场策略以适应不断变化的临床需求，从而采取果断行动，将市场动态转化为竞争优势。首先，他们应优先考虑模组化产品架构，该架构允许从基础血液学和生物化学检验扩展到更高级的分子和血清学检测，而无需巨额资本投入。这种方法降低了采用门槛，并透过升级途径促进了与客户的长期关係。同时，他们应投资于可靠的临床检验研究和跨物种比较参考数据，以证明其分析表现和在最常见伴侣动物群体中的临床效用。

透明的调查方法，解释资讯来源、专家参与、分析框架和局限性，以支持策略见解。

本分析的研究基础包括对同行评审的兽医临床文献、监管指导文件和产品技术规范进行系统性回顾，并结合对检查室管理人员、兽医、分销商和产品经理的直接访谈。在资料整合过程中，研究重点在于透过交叉检验多个资讯来源，检验技术能力、工作流程影响和区域部署模式。专家定性见解有助于解读临床效用和操作可行性，而二手资料则提供了有关监管和供应链趋势的背景资讯。

简明扼要地总结了伴侣动物诊断领域策略定位的技术、监管和商业性要求。

总之，伴侣动物诊断产业正处于策略转折点，技术进步、照护模式演变、监管政策调整和经济压力等因素相互作用，正在重塑其价值创造模式。分子层面的创新、增强的照护现场能力以及整合的数位化工作流程，在提高诊断准确性的同时，也改变了与传统检查室服务的关係。同时，政策措施和关税调整正促使供应商和经销商重新评估筹资策略，并增强区域供应链的韧性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 伴侣动物诊断市场：诊断测试类型

  • 血液学
    • 血液凝固检查
    • 血液常规检查（CBC）
  • 组织病理学
    • 切片检查
    • 细胞学
  • 诊断影像
    • 超音波检查
    • X射线
  • 分子诊断
    • DNA定序
    • PCR
  • 血清学
    • 聚集反应
    • ELISA检测

第九章 伴侣动物诊断市场：依产品类型划分

  • 消耗品
    • 试剂
    • 检测套组
  • 设备/分析仪
    • 临床化学分析仪
    • 血液检测设备
    • 免疫诊断分析仪
    • 分子诊断分析仪

第十章 伴侣动物诊断市场：依动物类型划分

  • 鸟类
  • 猫
  • 狗
  • 天竺鼠
  • 马

第十一章 伴侣动物诊断市场：依最终使用者划分

  • 院内检测设施
    • 动物收容所
    • 宠物饲主
  • 研究所
  • 兽医医院和诊所

第十二章 伴侣动物诊断市场：依应用领域划分

  • 内分泌检查
  • 基因检测
  • 感染疾病诊断
  • 营养分析
  • 肿瘤学
  • 药物监测
  • 毒性测试

第十三章 伴侣动物诊断市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 伴侣动物诊断市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 伴侣动物诊断市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国伴侣动物诊断市场

第十七章：中国伴侣动物诊断市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agrolabo SpA
  • Bio-Rad Laboratories, Inc.
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Demeditec Diagnostics GmbH
  • Eurofins Technologies
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Mars, Incorporated
  • Neogen Corporation
  • Nisseiken Co., Ltd
  • Qiagen NV
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-AD517FAA89C5

The Companion Animal Diagnostics Market was valued at USD 3.59 billion in 2025 and is projected to grow to USD 3.90 billion in 2026, with a CAGR of 8.94%, reaching USD 6.55 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.59 billion
Estimated Year [2026] USD 3.90 billion
Forecast Year [2032] USD 6.55 billion
CAGR (%) 8.94%

A concise orientation to the evolving companion animal diagnostics environment highlighting technological, clinical, and regulatory drivers reshaping care

The companion animal diagnostics landscape is undergoing a period of accelerated transformation driven by converging technological innovation, shifting clinical practices, and heightened owner expectations for more precise and timely veterinary care. Advances in assay design, imaging modalities, and molecular techniques are enabling earlier detection of disease, more personalized treatment pathways, and improved monitoring of therapeutic outcomes. As veterinary practices adopt more sophisticated in-house testing capabilities, the boundary between point-of-care screening and laboratory-grade diagnostics continues to blur, reshaping workflow models and service offerings across clinics and specialty centers.

Regulatory frameworks and professional guidelines are evolving in parallel, influencing validation standards, quality control expectations, and data governance practices for diagnostic tools and services. This dynamic regulatory context is prompting manufacturers and service providers to strengthen their evidence generation, claim substantiation, and post-market surveillance activities. Meanwhile, stakeholder expectations-from clinicians seeking rapid clinical decision support to pet owners demanding transparency and continuity of care-are incentivizing interoperable systems, standardized reporting formats, and clearer outcome metrics.

Taken together, these forces are redefining competitive differentiation. Companies that combine robust analytical performance with seamless integration into clinical workflows, strong customer support, and demonstrable clinical utility will secure the most durable positions in the market. The introduction sets the stage for a focused examination of these transformative shifts and their implications for players across the diagnostics ecosystem.

Clear articulation of the major transformative shifts altering diagnostic technologies, clinical workflows, and commercial models across veterinary practice

The landscape for companion animal diagnostics is being reshaped by several transformative shifts that are converging to redefine value propositions across the industry. First, the maturation of molecular diagnostics and next-generation sequencing has expanded the diagnostic toolkit beyond traditional morphology and serology, enabling precise pathogen identification, genetic risk profiling, and targeted oncology testing. Concurrently, point-of-care technologies and compact analyzers are decentralizing testing, allowing many practices to perform hematology, chemistry, and rapid infectious disease assays on-site, which shortens time-to-diagnosis and facilitates immediate clinical interventions.

Informatics and data integration are also rising to the fore. Cloud-based platforms, laboratory information systems, and diagnostic middleware are improving sample tracking, result interpretation, and longitudinal patient monitoring. This digital layer supports decision support algorithms and facilitates remote consultations, telemedicine follow-ups, and population-level surveillance of emerging pathogens. Additionally, growing adoption of standardized quality controls and accreditation programs is raising baseline expectations for analytical robustness across providers, which in turn influences procurement decisions and client trust.

Finally, economic and service delivery models are evolving: subscription-based service arrangements for reagents and consumables, bundled diagnostic packages, and value-based contracting for companion diagnostics are emerging as strategic approaches for suppliers. Organizations that embed clinical evidence generation, workflow integration, and responsive service models into their offerings will be better positioned to capture clinician adoption and long-term account relationships.

Practical analysis of how 2025 tariff adjustments are influencing supply chain resilience, regional sourcing strategies, and clinician procurement behavior

Tariff adjustments and trade policy changes slated for 2025 are creating a new set of operational considerations for manufacturers, distributors, and end-users in the companion animal diagnostics supply chain. Increased import duty levels on medical devices and reagents in select markets have compressed margins for vendors that rely on global sourcing, prompting a re-evaluation of distribution strategies, pricing models, and supplier relationships. Manufacturers with geographically diversified production footprints or flexible contract manufacturing arrangements are better able to mitigate near-term cost pressures and stabilize supply commitments to veterinary clinics and laboratories.

Beyond immediate cost implications, tariffs are catalyzing strategic shifts in supply chain architecture. Some suppliers are accelerating localization of component production and final assembly to reduce exposure to cross-border duties and shipping disruptions. This localization trend is influencing lead times, inventory policies, and capital investment decisions for facility expansions or partnerships. For end-users, procurement teams are revisiting total-cost-of-ownership calculations that incorporate tariff-driven price volatility, freight, and customs-related delays.

At the same time, tariff-driven market dynamics are influencing clinical adoption patterns. Where imported diagnostic platforms become less price-competitive, regional alternatives and modular in-house assay development may gain traction, especially in larger veterinary hospitals and research centers with capacity to validate new assays. Strategic collaboration between manufacturers and distributors to bundle services, offer extended warranties, and provide training can offset perceived cost increases and maintain continuity of clinical services amidst tariff-related uncertainty.

In-depth segmentation insights revealing how diagnostic test types, product classes, animal cohorts, end-user settings, and clinical applications shape strategic priorities

A granular segmentation lens clarifies where clinical need, technology fit, and commercial opportunity intersect across multiple diagnostic categories. The Type Of Diagnostic Test dimension includes hematology tests such as blood clotting assays and complete blood count panels, histopathology procedures encompassing both biopsy and cytology workflows, imaging modalities that cover ultrasound and X-ray diagnostics, molecular platforms spanning DNA sequencing and PCR-based assays, and serology approaches including agglutination assays and ELISA tests. Each test type carries distinct analytical requirements, specimen handling protocols, and training needs, which influence purchasing decisions across veterinary practices and reference laboratories.

Product Type segmentation differentiates consumables from instruments and analyzers, with consumables further characterized by reagents and test kits and instruments defined by categories such as clinical chemistry analyzers, hematology analyzers, immunodiagnostic analyzers, and molecular diagnostic instruments. This split underscores the divergent procurement rhythms between recurring reagent spend and capital expenditures for analyzers, shaping revenue models and sales strategies for suppliers.

Animal Type spans birds, cats, dogs, guinea pigs, and horses, and this diversity necessitates assay validation across species-specific reference ranges, sample matrix considerations, and clinical interpretation frameworks. End-User segmentation covers in-house testing facilities, research laboratories, and veterinary hospitals and clinics, with in-house testing facilities further segmented into animal shelters and pet owners, reflecting varying resource envelopes and technical capabilities. Application-focused segmentation includes areas such as endocrinology testing, genetic testing, infectious disease diagnostics, nutritional analysis, oncology, therapeutic drug monitoring, and toxicology testing; each application drives unique feature sets, regulatory needs, and evidence demands. Recognizing these intersecting segmentation vectors helps stakeholders prioritize product roadmaps, validation studies, and tailored commercial approaches for distinct end-user cohorts.

Strategic regional insights explaining how Americas, Europe Middle East & Africa, and Asia-Pacific markets diverge in adoption, regulation, and commercial models

Regional dynamics exert a powerful influence on technology adoption, regulatory pathways, and commercial execution strategies. In the Americas, a concentration of specialty veterinary practices and advanced reference laboratories favors rapid uptake of high-throughput molecular diagnostics and integrated practice-management workflows, supported by established distribution networks and a mature private practice ecosystem. In contrast, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with market fragmentation; established veterinary centers in Western Europe drive demand for validated, accredited solutions while emerging markets prioritize cost-effective, adaptable diagnostic options that address regional disease burdens.

In the Asia-Pacific region, rapid urbanization, growing pet ownership, and expanding veterinary education infrastructure are catalyzing demand for both point-of-care testing and advanced laboratory services. Local manufacturing and regional partnerships are increasingly important in Asia-Pacific, enabling faster market entry and responsiveness to price sensitivity. Across all regions, differences in reimbursement models, clinic consolidation trends, and professional training programs shape the pace and pattern of diagnostic uptake. Vendors must tailor their market entry strategies to account for these regional nuances, balancing standardized global product platforms with region-specific regulatory compliance, distribution frameworks, and service models to achieve sustainable adoption.

Actionable company-level insights highlighting competitive differentiation strategies, partnership pathways, and innovation priorities for sustained market relevance

Competitive dynamics within the companion animal diagnostics space are evolving as incumbent manufacturers, specialized instrument makers, reagent suppliers, and innovative molecular diagnostics firms seek differentiated value propositions. Success increasingly depends on integrated offerings that couple reliable instruments with validated consumables, streamlined workflows, and strong after-sales support. Companies that invest in clinical evidence generation, third-party validations, and cross-species reference data establish credibility with veterinary clinicians and laboratory directors, which helps sustain long-term procurement relationships.

Collaboration and strategic partnerships are emerging as effective pathways to accelerate market penetration. Alliances that combine diagnostic expertise with digital health platforms, telemedicine providers, or practice-management systems create compelling bundled solutions that address clinician workflow pain points and improve patient outcome tracking. Additionally, organizations that invest in training, remote diagnostics support, and technical service networks reduce adoption friction and enhance customer retention.

Innovation in reagent chemistry, microfluidics, and portable instrumentation is opening new competitive fronts where speed, ease of use, and assay robustness determine clinician preference. Firms that align product development with end-user realities-such as limited bench space, variable sample volumes, and the need for rapid actionable results-will command stronger market relevance. Finally, transparent post-market surveillance and responsiveness to regulatory developments reinforce trust and reduce adoption barriers for newer technologies.

Practical and prioritized recommendations for industry leaders to align product, evidence, pricing, and distribution strategies for clinical adoption and growth

Industry leaders can act decisively to convert market dynamics into competitive advantage by aligning product, evidence, and go-to-market strategies with evolving clinical needs. First, prioritize modular product architectures that allow clinics to scale capabilities from basic hematology and chemistry to more advanced molecular and serology testing without prohibitive capital outlays. This approach reduces adoption barriers and supports long-term customer relationships through upgrade pathways. In parallel, invest in robust clinical validation studies and cross-species reference data to demonstrate analytical performance and clinical utility across the most common companion animal cohorts.

Commercially, adopt flexible contracting models that combine capital equipment leasing, reagent subscription programs, and bundled service offerings to match the financial capacities of diverse end-users, from small clinics to large referral centers. Strengthen regional distribution by cultivating local manufacturing or assembly partnerships where tariff exposure or logistical constraints could undermine competitiveness. Complement product availability with targeted training programs, remote technical support, and quality assurance resources to minimize implementation friction and maximize clinician confidence.

Finally, integrate digital capabilities that enhance result interpretation, data sharing, and longitudinal patient tracking. Provide interoperable reporting formats that plug into practice-management systems and enable telemedicine workflows. By focusing on modularity, evidence generation, customer support, and digital integration, industry leaders will be positioned to capture long-term value as the companion animal diagnostics environment continues to mature.

Transparent research methodology explaining sources, expert engagement, analytical frameworks, and limitations to underpin the strategic findings

The research underpinning this analysis combined a structured review of peer-reviewed veterinary clinical literature, regulatory guidance documents, product technical specifications, and primary interviews with laboratory directors, veterinary clinicians, distributors, and product managers. Data synthesis emphasized triangulation across multiple sources to validate technology capabilities, workflow impacts, and regional adoption patterns. Qualitative inputs from subject-matter experts informed interpretation of clinical utility and operational feasibility, while secondary sources provided context on regulatory trajectories and supply chain dynamics.

Analytical methods included comparative feature mapping of diagnostic platforms, evaluation of assay validation approaches across species, and scenario analysis to assess tariff-driven supply chain responses. Emphasis was placed on reproducibility of findings and transparency of assumptions; where expert opinion informed projections about adoption likelihood or operational impacts, those judgements were corroborated with multiple practitioner interviews. Limitations include evolving regulatory actions and fast-moving technological developments that may shift dynamics after publication; accordingly, readers are encouraged to consider this research as a strategic compass that should be complemented with ongoing market monitoring and targeted validation in local practice settings.

The methodological approach ensures that the insights presented are grounded in practitioner realities, validated technical characteristics, and pragmatic commercial considerations, enabling decision-makers to apply findings to product development, procurement, and clinical integration strategies.

Concise conclusion synthesizing technological, regulatory, and commercial imperatives for strategic positioning in companion animal diagnostics

In conclusion, companion animal diagnostics stands at a strategic inflection point where technological advances, shifting care models, regulatory evolution, and economic pressures intersect to reshape value creation. The combination of molecular innovations, improved point-of-care capabilities, and integrated digital workflows is enhancing diagnostic precision while altering traditional laboratory-service relationships. Simultaneously, policy measures and tariff adjustments are prompting suppliers and distributors to reassess sourcing strategies and to strengthen regional supply resilience.

For stakeholders across the ecosystem, the path forward involves aligning product innovation with validated clinical utility, structuring commercial models that reflect end-user financial realities, and investing in service frameworks that reduce adoption friction. Regional nuance matters: targeted market approaches that consider local regulatory environments, distribution infrastructures, and clinical practice patterns will outperform one-size-fits-all strategies. Ultimately, organizations that balance technical excellence with pragmatic commercialization-backed by evidence, training, and responsive support-will lead the next phase of adoption and deliver measurable clinical and business value.

This conclusion synthesizes the principal insights and underscores the imperative for proactive strategy development to capture opportunity and mitigate operational risk in a rapidly evolving diagnostics environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Companion Animal Diagnostics Market, by Type Of Diagnostic Test

  • 8.1. Hematology
    • 8.1.1. Blood Clotting Test
    • 8.1.2. Complete Blood Count (CBC)
  • 8.2. Histopathology
    • 8.2.1. Biopsy
    • 8.2.2. Cytology
  • 8.3. Imaging
    • 8.3.1. Ultrasound
    • 8.3.2. X-Rays
  • 8.4. Molecular Diagnostics
    • 8.4.1. DNA Sequencing
    • 8.4.2. PCR
  • 8.5. Serology
    • 8.5.1. Agglutination Assay
    • 8.5.2. Elisa Test

9. Companion Animal Diagnostics Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Reagents
    • 9.1.2. Test kits
  • 9.2. Instruments/Analyzers
    • 9.2.1. Clinical chemistry analyzers
    • 9.2.2. Hematology analyzers
    • 9.2.3. Immunodiagnostic analyzers
    • 9.2.4. Molecular diagnostic analyzers

10. Companion Animal Diagnostics Market, by Animal Type

  • 10.1. Birds
  • 10.2. Cats
  • 10.3. Dogs
  • 10.4. Guinea pigs
  • 10.5. Horses

11. Companion Animal Diagnostics Market, by End-User

  • 11.1. In-House Testing Facilities
    • 11.1.1. Animal Shelters
    • 11.1.2. Pet Owners
  • 11.2. Research Laboratories
  • 11.3. Veterinary Hospitals & Clinics

12. Companion Animal Diagnostics Market, by Application

  • 12.1. Endocrinology Testing
  • 12.2. Genetic Testing
  • 12.3. Infectious Disease Diagnostics
  • 12.4. Nutritional Analysis
  • 12.5. Oncology
  • 12.6. Therapeutic Drug Monitoring
  • 12.7. Toxicology Testing

13. Companion Animal Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Companion Animal Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Companion Animal Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Companion Animal Diagnostics Market

17. China Companion Animal Diagnostics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agrolabo S.p.A.
  • 18.6. Bio-Rad Laboratories, Inc.
  • 18.7. Biogal Galed Labs
  • 18.8. BioMerieux S.A.
  • 18.9. BioNote, Inc.
  • 18.10. Demeditec Diagnostics GmbH
  • 18.11. Eurofins Technologies
  • 18.12. Fassisi GmbH
  • 18.13. FUJIFILM Holdings Corporation
  • 18.14. IDEXX Laboratories, Inc.
  • 18.15. IDvet
  • 18.16. Mars, Incorporated
  • 18.17. Neogen Corporation
  • 18.18. Nisseiken Co., Ltd
  • 18.19. Qiagen N.V.
  • 18.20. Randox Laboratories, Ltd.
  • 18.21. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 18.22. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 18.23. SKYER, Inc.
  • 18.24. Skyla Corporation
  • 18.25. Thermo Fisher Scientific Inc.
  • 18.26. Vimian Group AB
  • 18.27. Virbac S.A.
  • 18.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 265. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 272. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 275. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-20